Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgkin's Lymphoma
A study to determine the accuracy of FLT-PET in quantifying tumor cell proliferation at the initial staging of patients with Non-Hodgkin's Lymphoma in comparison wit the "gold standard" FDG-PET.
|Study Design:||Observational Model: Case Control
Time Perspective: Prospective
|Official Title:||Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgknin's Lymphoma|
- Staging and ReStaging scans [ Time Frame: after hematopoetic recovery ] [ Designated as safety issue: No ]
|Study Start Date:||October 2008|
Procedure: FLT-PET scan
Procedure: FDG-PET scan
The first primary objective reflects a necessary and preliminary requirement: to reproduce published results and validate the use of FLT-PET. In this study, 35 patients will be selected to undergoing imaging with both FLT and FDG PET.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00775957
|United States, Oklahoma|
|University of Oklahoma Health Sciences Center|
|Oklahoma City, Oklahoma, United States, 73104|